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ABSTRACT
Splicing of eukaryotic pre-mRNA is carried out by
the spliceosome, which assembles stepwise on each
splicing substrate. This requires the concerted ac-
tion of snRNPs and non-snRNP accessory proteins,
the functions of which are often not well understood.
Of special interest are B complex factors that enter
the spliceosome prior to catalytic activation and may
alter splicing kinetics and splice site selection. One
of these proteins is FBP21, for which we identified
several spliceosomal binding partners in a yeast-
two-hybrid screen, among them the RNA helicase
Brr2. Biochemical and biophysical analyses revealed
that an intrinsically disordered region of FBP21 binds
to an extended surface of the C-terminal Sec63 unit of
Brr2. Additional contacts in the C-terminal helicase
cassette are required for allosteric inhibition of Brr2
helicase activity. Furthermore, the direct interaction
between FBP21 and the U4/U6 di-snRNA was found
to reduce the pool of unwound U4/U6 di-snRNA. Our
results suggest FBP21 as a novel key player in the
regulation of Brr2.
INTRODUCTION
The removal of non-coding introns from eukaryotic pre-
mRNAs during pre-mRNA splicing is carried out by the
spliceosome, a large molecular machine consisting of five
small nuclear ribonucleoprotein particles (snRNPs,U1,U2,
U4, U5 and U6 for the major spliceosome or U11, U12,
U4atac, U5 and U6atac for the minor spliceosome) and
a plethora of non-snRNP proteins. Unlike other macro-
molecular machines, the spliceosome assembles de novo for
each splicing reaction in a step-wise manner. Firstly, the 5′
splice site, the 3′ splice site and branch point are defined,
involving the sequential binding of U1 and U2 snRNPs
(A complex). Recruitment of the U4/U6•U5 tri-snRNP
then leads to the formation of the pre-catalytic B complex.
Major compositional and conformational rearrangements
through the action of spliceosomal helicases lead to a grad-
ual activation of the spliceosome (Bact and B* complexes),
which then carries out the two consecutive steps of the splic-
ing reaction before it is disassembled and its components
are recycled (1).
This description of the splicing cycle has been derived
primarily from structural and functional studies of the
spliceosome ofSaccharomyces cerevisiae, which is a popular
model organism due to its genetic tractability and relative
simplicity. The core components of splicing are well con-
served fromyeast to human (2).However, while less than 5%
of S. cerevisiae protein-coding genes contain introns (3,4),
there are an average of 7.8 introns per gene in Homo sapi-
ens (5–7) and human splice site and branch point sequences
are more divergent. In addition, most human mRNAs un-
dergo alternative splicing, which means that exons can be
skipped, introns can be retained or alternative 5′ or 3′ splice
sites can be used (8). Pervasive alternative splicing requires
a higher level of regulation, which is also reflected in the
larger number of spliceosomal proteins in higher eukary-
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otes (2). Equally, higher complexity gives room for dysreg-
ulation and disease (9) and splicing defects have been associ-
atedwith inherited diseases, neurodegenerative diseases and
cancer (10–12).
A group of proteins that may be of particular interest
for splice site decisions are proteins that are present ex-
clusively in the B complex (B complex-specific proteins),
as they act directly before spliceosomal catalytic activa-
tion, which fixes the specific splicing pattern of a substrate
through irreversible loss of U4 (13). In the transition from
the B to the Bact complex, the RNA helicase Brr2 unwinds
the U4/U6 duplex, releasing the U4 snRNP and enabling
the U6 snRNA to base-pair with the U2 snRNA and to
form a catalytically important stem–loop (14,15). It is thus
a key player in spliceosomal activation.
Brr2 has a unique domain architecture, consisting of
two similar helicase cassettes of which only the N-terminal
cassette is catalytically active. Both helicase cassettes con-
tain two RecA domains followed by a winged helix do-
main (WH) and a Sec63 unit, which is composed of
a helical bundle (HB), a helix-loop-helix (HLH) and
an immunoglobulin-like (IG) domain. In addition, Brr2
contains an approximately 450-residue N-terminal region
(Brr2NTR).
Brr2 already encounters the U4/U6 di-snRNP in the
U4/U6•U5 tri-snRNP and remains associated with the
spliceosome after catalytic activation (16–18). Thus, Brr2
is tightly regulated by various mechanisms for splicing to
proceed in an ordered manner (19). Regulation of the heli-
case is achieved intramolecularly via the C-terminal cassette
and via the Brr2NTR (16,17,20,21), which activate or inhibit
the helicase, respectively. The C-terminal cassette interacts
with the enzymatically active N-terminal cassette through
a large interface (21), thereby acting as an intramolecular
modulator of activity. The Brr2NTR contains several func-
tional units implicated in inhibition of the helicase, which
interact both with the N- and C-terminal helicase cassette
(20).
Brr2 is additionally regulated by trans-acting factors, pri-
marily by the C-terminal Jab1 domain of the spliceoso-
mal Prp8 protein (Prp8Jab1). Prp8 is the largest spliceoso-
mal protein, which scaffolds the assembly of the catalytic
core of the spliceosome (22,23). Prp8Jab1 interacts with the
Sec63 unit of the N-terminal cassette and can intermittently
inhibit Brr2 by insertion of its intrinsically unstructured C-
terminal tail into the Brr2 RNA-binding tunnel (24). In
contrast, after removal of the tail, Prp8Jab1 acts as a strong
activator of the Brr2 helicase (24,25), an effect that is re-
capitulated by a C-terminally truncated version of the Jab1
domain (Prp8Jab1C) (26).
The C-terminal helicase cassette has been postulated as a
binding platform (27–29), but few interaction partners are
known to date (28,30). Given the role of the C-terminal heli-
case cassette in regulatingBrr2 activity it is of critical impor-
tance to identify proteins that bind to this region, thereby
conceivably altering the kinetics of spliceosome activation
in trans. B complex proteins would be particularly suitable
to alter splicing fates by regulating Brr2 as they are present
directly prior to Brr2 activity.
Of the eight B complex-specific proteins (Smu1, RED,
MFAP1, FBP21, Snu23, Prp38, TFIP11 and Prp4-Kinase)
(31), Smu1, RED, MFAP1 and FBP21 do not have an ob-
vious S. cerevisiae homolog (31). Smu1, RED and MFAP1
have been studied structurally in context with other mem-
bers of the B-complex (32–34). For Smu1 and RED, func-
tional data is also available (32,35). However, little is known
about the function of FBP21.
FBP21 contains two WW domains, for which an NMR
structure is available (36). In addition, it is predicted to
contain a matrin-type zinc finger in its N-terminal region
(residues 11–42). The remainder of the protein appears to
be intrinsically disordered. The tandem WW domains of
FBP21 have been studied comprehensively. They interact
with proline-rich sequence (PRS)-containing spliceosomal
proteins such as SmB/B’, SF3B4 and SIPP1 (36–38) and
localize to nuclear speckles upon overexpression (36). Over-
expression of FBP21 or its isolated tandem WW domains
was shown to increase splicing efficiency of a reporter con-
struct (36). In addition, FBP21 was suggested to modulate
VEGF-A alternative splicing in the context of insulin-like
growth factor 1 signaling (39).
FBP21 has no apparent catalytic activity, thus it likely
fulfills its function by interaction with other spliceosomal
components. The binding of all known interaction partners
is mediated by WW domain-PRS interactions, which are
typically of low affinity and high promiscuity (37) and thus
barely yield information about FBP21’s specific spliceoso-
mal function. Therefore, we set out to identify molecules of
the spliceosome interacting with FBP21 independent of its
WW domains. Strikingly, we identified a novel interaction
between FBP21 and the spliceosomal RNA helicase Brr2




The yeast-two-hybrid assay was carried out as described
previously (40) using the prey matrix established in
(34). FBP21FL (1–376) and mutants FBP21FL W150A,
FBP21FL W191A, FBP21FL W150A/W191A as well
as the fragments FBP211-50, FBP211–200, FBP21tWW
(117–200), FBP21tWW W29A, FBP21tWW W70A,
FBP21tWW W29A/W70A, FBP21tWW linker,
FBP21117–376, FBP21117–376 W29A/W70A and
FBP21200–376 were cloned into pBTM-116-D9 and
pBTM-CC24-DM vectors by Gateway cloning using
standard procedures. Interacting bait-prey pairs were iden-
tified by growth on selective agar plates (lacking leucine,
tryptophane, adenine, uracile and histidine). Growth was
categorized into no growth (score = 0), weak growth (score
= 1), medium growth (score = 2) and strong growth (score
= 3). For each interacting protein the scores of all growing
yeast spots were added to a final count. Only those pairs
which showed a score of at least three were considered as
a putative interaction. All bait constructs which were auto
active and all prey constructs which had been previously
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Protein expression and purification
FBP21200–376, FBP21276–376, FBP21326–376, FBP21200–376
K357E/R359E, FBP21200–376 K358A/R360A and
FBP21116–376 were expressed from pETM11 (EMBL,
Heidelberg) vectors in Escherichia coli BL21-DE3 at
37◦C for 4–4.5 h. Isotope-labeled proteins for NMR were
produced in E. coli using M9 minimal medium, which was
supplemented with amino acids for amino acid specific la-
beling and based onD2O for protein deuteration. The pellet
was resuspended in IMAC lysis buffer (50 mM KH2PO4,
300 mM KCl, 5 mM imidazole pH 8.0) supplemented
with protease inhibitors (Roche) and lysed by sonication.
The His-tagged proteins were subjected to affinity chro-
matography using a Ni-NTA column (Macherey-Nagel).
During an overnight dialysis at 4◦C to 10 mM Tris pH 8,
50 mM NaCl, the His-tag was removed by TEV protease.
The cleaved protein was loaded on a Mono-Q 5/50 GL
column (GE Healthcare) equilibrated with 10 mM Tris
pH 8, 50 mM NaCl and eluted with a linear 50 to 1500
mM NaCl gradient and further purified by size exclusion
chromatography using a HiLoad Superdex 75 column
(GE Healthcare) in 10 mM Tris pH 7.5, 100 mM NaCl.
Brr2C-Sec63 was expressed from a pGEX6p vector in E. coli
BL21-DE3 for 37◦C for 4 h. The pellet was resuspended
in GST lysis buffer (150 mM NaCl, 20 mM Na2HPO4, 10
mM EDTA pH 7.4) supplemented with protease inhibitors
(Roche) and lysed by sonication. The GST-tagged proteins
were subjected to affinity chromatography using a Glu-
tathione 4B column (Macherey-Nagel). The eluted protein
was subjected to size exclusion chromatography using a
HiLoad Superdex 75 column (GE Healthcare) in 10 mM
Tris pH 7.5, 100 mMNaCl. The GST-tag was cleaved using
PreScission protease for 16 h at 4◦C. The cleaved GST-tag,
uncut protein and protease were removed by GST affinity
chromatography and the target protein was further purified
by size exclusion chromatography in 10 mM Tris, pH 7.5,
100 mM NaCl.
Brr2NC, Brr2CC, Brr2HR, Brr2FL were expressed in insect
cells and purified as described (41). Briefly, High FiveTM cell
pellets were resuspended in 50mMHEPES-NaOH, pH 8.0,
600 mM NaCl, 2 mM -mercaptoethanol, 0.05% NP40,
1.5 mMMgCl2, 20% (v/v) glycerol, 10 mM imidazole, sup-
plemented with EDTA-free protease inhibitor (Roche) and
lyzed by sonication using a Sonopuls Ultrasonic Homoge-
nizerHD3100 (Bandelin). The target was captured from the
cleared lysate on a 5 ml HisTrap FF column (GE Health-
care) and eluted with a linear gradient from 10 to 250 mM
imidazole. The eluted protein was diluted to a final concen-
tration of 80 mM NaCl, treated with RNaseA and loaded
on a Mono Q 10/100 GL column (GE Healthcare) equi-
librated with 50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 5%
(v/v) glycerol, 2 mM -mercaptoethanol. The protein was
eluted with a linear 0.05 to 1.5 M NaCl gradient and fur-
ther purified by gel filtration on a 16/60 Superdex 200 gel
filtration column (GE Healthcare) in 40 mM Tris–HCl, pH
8.0, 200 mM NaCl, 20% (v/v) glycerol, 2 mM DTT. The
GST-tagged Prp8Jab1C was expressed in High FiveTM cells.
Cell pellets were resuspended in binding buffer containing
50mMTris, pH8.0, 300mMNaCl, 5% (v/v) glycerol, 1mM
DTT, 0.05% NP40 supplemented with EDTA-free protease
inhibitors and DNase I. The suspension was then lysed by
sonication using a Sonopuls Ultrasonic Homogenizer HD
3100 (Bandelin), cell debris was removed by centrifugation
and the soluble extract was filtered. The clear lysate was
loaded onto GSH beads previously equilibrated with bind-
ing buffer and incubated 1 h at 4◦C with gentle agitation.
After washing the beads with 10 column volumes (CV) of
binding buffer, the beads were incubated overnight with
PreScission protease at 4◦C. The cleaved protein was then
collected as the flow through and the beads were washed
with 2 CV of binding buffer to wash away all the cleaved
protein from the beads. The flow through and wash frac-
tions were collected, concentrated and loaded onto a S200
gelfiltration column equilibrated in Tris 10 mM pH 8.0, 150
mM NaCl and 1 mM DTT.
Cross-linking analysis
The primary amino group-reactive cross-linker BS3 (Pierce,
Thermo Scientific) was used for cross-linking analysis.
Brr2CC, Brr2HR, Brr2FL were purified in complex with
FBP21200–376. 25 pmol of complex were cross-linked with
6 nmol BS3 in 20 mM HEPES–NaOH pH 7.3, 200 mM
NaCl, 2 mMDTT and 5% (v/v) glycerol and incubated for
30 min at room temperature. The reaction was quenched
with 1 l of 1 M Tris–HCl. For Brr2CC, the cross-linked
sample was separated by SDS-PAGE, the band correspond-
ing to the cross-linked complex was excised and the proteins
were in-gel digested with trypsin. The peptides were dis-
solved in 5% acetonitrile and 0.1% formic acid forMS anal-
ysis. For Brr2FL and Brr2HR, the cross-linked complexes
were pelleted by ultracentrifugation, dissolved in 4 M urea
and 50 mM ammonium bicarbonate, reduced with DTT
and alkylated with iodoacetamide. After dilution to 1 M
urea, the complexes were digested with trypsin. Peptides
were reverse-phase extracted and fractionated by size ex-
clusion chromatography on a Superdex peptide PC3.2/300
column (GE Healthcare). Mass spectrometric analysis was
performed on a Thermo Scientific Orbitrap Fusion Tribrid
mass spectrometer coupled to a nano-LC system (UltiMate
3000 RSLCnano system). Protein-protein cross-links were
identified by the pLink 1.22 search engine and filtered at
FDR 1% (42). Cross-links which connected the N-terminal
amino group of FBP21200–376 to lysine residues of Brr2 were
disregarded, as the N-terminus of FBP21200–376 is artificial.
NMR spectroscopy
All NMR spectra were recorded on a Bruker Avance 700
MHz spectrometer equipped with a 5 mm triple reso-
nance cryoprobe. Spectra were processed using TopSpin3.1
(Bruker) and analyzed using CCPNMR Analysis 2.2.2.
(43). Triple resonance spectra (HNCA,HNCOCA,HNCO,
HNCACO and 1H–15N-NOESY) for backbone assign-
ments were recorded with 2H–15N-13C-labeled Brr2C-Sec63
at concentrations of 200–500 M in 10 mM sodium phos-
phate pH 7.0, 100 mM NaCl supplemented with 10% D2O
at 300 K. Non-uniform sampling (25%) was used to re-
duce measurement time. Assignment of the HSQC signals
was accomplished using CCPNMRAnalysis 2.2.2 (43) and
chemical shift predictions derived from the crystal struc-
ture of Brr2C-Sec63 (part of PDB ID 4F91) using ShiftX2
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(44). All 1H–15N-TROSY-HSQC spectra of amino acid-
selectively labeled Brr2C-Sec63 (Leu, Ala (-Trp), Ile, Val, Gly
(–Ser, –Cys), Trp–Tyr, Tyr–Phe) were measured at 100–
300 M in 10 mM sodium phosphate pH 7.0, 100 mM
NaCl supplemented with 10% D2O at 300 K with 32–
128 scans depending on the concentration and 1024 ×
96 datapoints. All 1H–15N-TROSY-HSQC spectra of uni-
formly labeled proteins were measured at 100 M in 10
mM Tris, 100 mM NaCl pH 7.5 supplemented with 10%
D2O at 300 K with 32 scans and 1024 × 96 datapoints.
NMR spectra of 15N-labeled FBP21276–376 were measured
at a concentration of 100 M with a 2-fold excess of
Brr2C-Sec63. NMR spectra of 15N-labeled Brr2C-Sec63 were
measured at a concentration of 100 M with a two-fold
excess of ligand (FBP21276–376, FBP21200–376 K357ER359E
and FBP21326–376 and FBP21276–376), a four-fold excess of
ligand (FBP21276–376) or a seven-fold excess of ligand (pep-
tide 57 GVMADGVAPVFKKRRTENGK and peptide 58
GVAPVFKKRRTENGKSRNLR). For the NMR titra-
tions, spectra were acquired with 100 M Brr2C-Sec63 and
12.5, 25, 50, 75, 100, 150, 200 and 400 M FBP21276–376.
Assignments of the unbound Brr2C-Sec63 were transferred
to the nearest neighbors of the bound state, employing
amino-acid-type selectively-labeled Brr2C-Sec63 in complex
with FBP21276–376 to help identifying longer shift distances.
Chemical shift differences were calculated by {1H/15N
= SQRT((1H)2 + (0.15*15N)2} and were considered to be
strongly shifting when they exceeded the average plus stan-
dard deviation and weakly shifting when they exceeded the
average chemical shift distance. The chemical shift changes
were plotted on the structure using the PyMOL Molecular
Graphics System, Version 1.8 Schro¨dinger, LLC. For sol-
uble paramagnetic relaxation enhancement (PRE) experi-
ments, Gadopentetic acid (Gd(DTPA)2−) was used at 0, 2,
5 and 10 mM with Brr2C-Sec63 alone or in complex with
FBP21276–376. All 1H–15N-TROSY-HSQC spectra for PRE
experiments were recorded at 100 M Brr2C-Sec63 and 200
M FBP21276–376 (if applicable) in 10 mM Tris, 100 mM
NaCl pH 7.5 supplemented with 10% D2O at 300 K with
32 scans and 1024 × 96 datapoints. Peak intensities of all
single assigned peakswere extracted usingCCPNMRAnal-
ysis (43). To obtain a value for the intensity loss, the peak
intensities of the Gd(DTPA)2−-samples were divided by the
peak intensities of the spectrum without Gd(DTPA)2−, al-
ways with and without ligand. Subsequently, the intensity
loss of each peakwith ligandwas subtracted from each peak
without ligand. Values above the overall average difference
plus standard deviation (0.33) were considered a strong pro-
tection from the PRE, values above the average difference
(0.16) a weak protection. Likewise, values below the neg-
ative average difference minus standard deviation (−0.33)
were considered a strong deprotection, values below the
negative average difference (−0.16) a weak protection.
Peptide SPOT analysis
Peptide SPOT analyses were performed as described (38).
Briefly, membranes were blocked with 5% BSA in 20 mM
Tris pH 7.4, 150 mM NaCl, 2 mM DTT, washed and
incubated with His-Brr2NC, His-Brr2CC, His-Brr2HR or
His-Brr2FL at a concentration of 25 g/ml (His-Brr2NC,
His-Brr2CC), 50 g/ml (His-Brr2HR) or 60 g/ml (His-
Brr2FL), respectively, overnight at 4◦C. The SPOT arrays
were washed and then incubated with an HRP-coupled
anti-His antibody (Miltenyi Biotech) for 1 h at room tem-
perature in blocking buffer and washed again. The Pep-
tide Spot Arrays were developed with HRP juice purchased
from p.j.k. GmbH on an Intas Advanced Fluorescence and
ECL imager.
Isothermal titration calorimetry
All ITC experiments were carried out using a MicroCal
ITC200 (Malvern) at 25◦C. Where possible, both bind-
ing partners were dialyzed against the ITC buffer (10 mM
Tris pH 7.5, 100 mM NaCl). Peptides were dissolved in
ITC buffer and the pH was adjusted. For all experiments
with Brr2C-Sec63 and FBP21 fragments except peptide 58,
Brr2C-Sec63 was in the cell and the FBP21 ligand in the sy-
ringe. For ITC experiments with FBP21200–376, FBP21276–376
FBP21326–376 and FBP21116–376, Brr2C-Sec63 was concen-
trated to 30 M and the FBP21 fragment to 400 M.
For experiments with the peptides and FBP21 mutants,
Brr2C-Sec63 was concentrated to 50 M, the peptide to 800
M and the mutants to 600 M. For experiments with
Brr2C-Sec63 and peptide 58, peptide 58 used at 30 M in
the cell and Brr2C-Sec63 at a concentration of 400 M in
the syringe. For experiments with FBP21116–376 and SmB-
peptide, FBP21 was in the cell at a concentration of 100M
and SmB-peptide in the syringe at a concentration of 2mM.
For experiments with all three components, either 400 M
FBP21116–376 and 2 mM SmB peptide were pre-incubated
together and used as a ligand for 30 M Brr2C-Sec63, or
100 M Brr2C-Sec63 and 100 M FBP21116–376 were pre-
incubated and used with 2 mM SmB peptide as a ligand.
In the control, 200 M Brr2C-Sec63 and 4 mM SmB pep-
tide were used. The experiment started with one injection
of 1 l followed by 25 injections of 2 l. The data was ana-
lyzed with Origin and the Microcal ITC 200 AddOn to ob-
tain stoichiometry, association constant, reaction enthalpy
and reaction entropy. The baseline was corrected, the first
point was removed and the enthalpy of solvation was sub-
tracted. The peak areas were integrated and reaction heats
were plotted against the molar ratio of titrant versus ana-
lyte. The data was fitted with the model for one binding site
using the Microcal ITC 200 Add-on in Origin.
Preparation of 32P-labeled U4 and U4/U6 duplex snRNA
RNAs and duplexes were prepared as in (26). Briefly, U4
and U6 were produced by T7 RNA polymerase-based in
vitro transcription.U4was dephosphorylated and 5′ labeled
using T4 polynucleotide kinase and  32P-ATP. For duplex
preparation U4 was annealed with U6 and purified by na-
tive PAGE, PCI extraction and ethanol precipitation.
Electrophoretic mobility shift assays (EMSA)
1 nM 32P-labeled U4/U6 duplex snRNA was titrated with
increasing amounts of Brr2 alone or in presence of 600 nM
or 5 MFBP21200–376 or FBP21276–376 or FBP21 fragments
alone in 40mMHEPES–NaOH (pH 7.9), 15mMNaCl, 2.5
Downloaded from https://academic.oup.com/nar/article-abstract/45/13/7922/3894166/A-new-role-for-FBP21-as-regulator-of-Brr2-helicase
by guest
on 08 September 2017
7926 Nucleic Acids Research, 2017, Vol. 45, No. 13
mMNaOAc, 1 mMDTT and 0.1 mg/ml acetylated BSA in
appropriate concentration ranges. Samples were separated
by native PAGE using a 4% (75:1) gel for Brr2 and a 6%
(19:1) gel for FBP21. Gels were scanned on a Storm Phos-
phorImager (GEHealthcare) and bands were quantified us-
ing ImageQuant software. Fitting the resulting data points
to a single exponential Hill function {fraction bound =
A[protein]n/([protein]n +KD}, in whichA is the fitted maxi-
mum of boundU4/U6 snRNA and n is the Hill coefficient}
using GraphPad Prism yielded apparent KD values.
Unwinding assays
Unwinding assays were performed as described (21,41).
100 nM Brr2 were incubated with 2 nM 32P-labeled U4/U6
di-snRNA at 30◦C in a buffer containing 40 mM Tris pH
7.5, 50 mM NaCl, 5 mMMgCl2, 1.5 mM DTT, 0.1 mg/ml
acetylated BSA, 8% (v/v) glycerol with or without FBP21.
After addition of 1 mM ATP/MgCl2, 10 l of the reaction
were taken and quenched with 10 l stop buffer (40 mM
Tris pH 7.4, 50 mM NaCl, 25 mM EDTA, 1% SDS, 10%
(v/v) glycerol, 0.05% xylenecyanol and 0.05% bromophe-
nol blue) at the respective time points. In addition, a sam-
ple was taken and boiled to fully disrupt the RNA duplex.
The samples were separated by native PAGE using a 6%
(19:1) gel. Gels were scanned on a Storm PhosphorImager
(GE Healthcare). Quantification of the bands was carried
out using the ImageQuant software. After background cor-
rection, band intensities were extracted and the percentage
of unwound duplex is calculated and plotted over time and
fitted with GraphPad Prism (GraphPad Software, Inc.) to
a first-order reaction {U4/U6 snRNA unwound = A[1 −
exp(−kut)], in which A is the amplitude of the reaction, ku
the apparent rate of unwinding and t is time}.
RESULTS
A yeast-two-hybrid screen identifies Brr2 as a binding partner
of FBP21
In order to identify possible binding partners for FBP21 in
the spliceosome, we conducted a yeast-two-hybrid (Y2H)
screen against a spliceosomal matrix composed of 237 pro-
teins represented by 442 clones of full length human spliceo-
somal proteins and fragments encompassing domains or
predicted folding units (34). By using various fragments
of FBP21 as well as mutants that prevented binding to
PRS via one or both WW domains (W150A, W191A
or W150A/W191A, respectively) as bait proteins (domain
structure shown in Figure 1A), we identified 15 high-
confidence binding partners (Table 1) and roughly mapped
their interaction sites.
All bait constructs containing two intact WW domains
or the intact WW2 domain were transcriptionally auto-
activating. This prevented the identification of well-known
interaction partners that bind FBP21 via PRS. Neverthe-
less, full-length FBP21 containing an intact WW1 domain
interacted with numerous proteins, some of which con-
tained proline-rich bindingmotifs (hnRNPK, ISY1, SIPP1,
SF3A1, Prp16 and Prp43, Table 1). Some of these inter-
action partners (SF3A1, SIPP1, hnRNPK) were detected
previously in pull-down approaches (36,37). More inter-
estingly, we identified interaction partners independent of
FBP21’s WW domains. For several of those (MORG1,
SKIP, PPIH, FAM164A and FAM50B), a binding re-
gion could not be derived, since they interacted only with
full length constructs. TIA-1 and ARGLU-1, two proteins
known to bind pre-mRNAs and to influence gene expres-
sion (45,46) and alternative splice site decisions (47–49)
bound to the N-terminal region containing the predicted
zinc finger of FBP21. However, the top hit of the screen
represented by the largest number and size of growing yeast
clones was the RNA helicase Brr2, which interacted with
the C-terminal region of FBP21.
Validation of the interaction between FBP21 and Brr2
As Brr2 plays a key role in the spliceosome, we concen-
trated on further characterization of the interaction be-
tween FBP21 and Brr2. The shortest fragments, for which
a Y2H interaction was observed, were the C-terminal re-
gion of FBP21 (FBP21200–376) and the C-terminal Sec63
unit of Brr2. The interaction between FBP21200–376 and
Brr2 was validated in vitro by size exclusion chromatogra-
phy (Supplementary Figure S1). Binding was observed with
the C-terminal (Brr2CC, residues 1282–2136) but not the N-
terminal helicase cassette (Brr2NC, residues 395–1324). The
region encompassing both helicase cassettes (Brr2HR, 395–
2129) also stably interacted with FBP21200–376. The inter-
action between FBP21200–376 and full-length Brr2 (Brr2FL)
was weakened by the presence of the Brr2NTR.
To delineate interacting regions of the two proteins,
FBP21200–376 was chemically cross-linked to Brr2CC,
Brr2HR and Brr2FL (constructs shown Figure 1A) and
cross-linking sites were identified by mass spectrometry
(Figure 1B). The cross-link between FBP21 K338 and Brr2
K1874 was the predominant site with 25, 28 and 21 spectral
counts for Brr2CC, Brr2HR and Brr2FL, respectively. This
could thus indicate the major interaction site (Figure
1C). Overall, cross-links concentrated on one face of the
C-terminal Sec63 unit (Brr2C-Sec63, residues 1840–2136),
consistent with data from the Y2H assay, which showed
the Sec63 unit as the shortest Brr2 fragment interacting
with FBP21. In addition, nearly all cross-links involved the
C-terminal 100 residues of FBP21 (FBP21276–376).
FBP21276-376 interacts with Brr2C-Sec63 via a complex inter-
face
2D NMR experiments were used to analyze the interaction
between Brr2C-Sec63 and FBP21276–376 in more detail. First,
we isotopically labeled FBP21276–376 and recorded a 1H–
15N-TROSY-HSQC spectrum with and without Brr2C-Sec63
(Figure 2A). The spectrum of FBP21276–376 showed very
low chemical shift dispersion, consistent with an intrinsi-
cally disordered protein region (IDPR). Upon interaction
with Brr2C-Sec63, several resonances exhibited chemical shift
changes or line broadening. The spectrum of the complex
suggests that the FBP21 fragment globally retains its un-
structured nature when bound to Brr2C-Sec63 and does not
adopt a stable fold upon complex formation.
Next, we isotopically labeled Brr2C-Sec63 and recorded
1H–15N-TROSY-HSQC spectra with and without
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Count Example Count Example Count Example Count Example
SNRNP200(Brr2) 15 18 - 3
CYPH (PPIH) 19 19 - -
SF3b145 (SF3B2) 20 10 - -
SKIP (SNW1) 7 4 - -
MORG1 (WDR83) 3 1 - -
FAM164A 6 4 - -
FAM50B 6 4 - -
TIA1 - - 3  -
ARGLU1 5 - 3 -
hnRNPK 4 - - -
ISY1 4 - - -
WBP11 20 - -
SF3A1 4 - - -
PRP16 (DHX38) 7 - - -
PRP43 (DHX15) 3 - - -
Fifteen high confidence hits were obtained in the yeast-two-hybrid screen with different constructs of FBP21. The putative interaction partners are orga-
nized by the interaction site on FBP21. The count is derived from the number and growth of yeast from each interaction pair.
FBP21276–376 (Figure 2B). The interaction resulted in
substantial changes of the Brr2C-Sec63 signals, suggesting
a large binding interface or conformational changes in
Brr2C-Sec63 upon FBP21276–376 binding. To better under-
stand this behavior and gain information about the FBP21
binding site on Brr2, we assigned the resonances of the
Brr2C-Sec63 spectrum to the backbone-NH-groups. Using
conventional triple-resonance spectra in combination with
amino acid type-specific labeling (Supplementary Figure
S2), we were able to confidently assign the backbone
resonances of 78% of the residues of free Brr2C-Sec63 and
transfer assignments to FBP21276–376-bound Brr2C-Sec63.
Titration of FBP21276–376 to Brr2C-Sec63 (Supplementary
Figure S3) revealed that most affected resonances showed
line broadening at intermediate ligand concentrations, sug-
gesting that the interaction takes place in the intermediate
to slow exchange regime relative to the NMR timescale.
Mapping the combined 1H–15N-chemical shift differences
of Brr2C-Sec63 upon addition of FBP21276–376 (Supplemen-
tary Figure S3) onto the crystal structure of Brr2C-Sec63
(PDB ID 4F91; Figure 2C) revealed that the residues with
the largest chemical shift differences were located in the
HLH domain (residues 1958–2020) and adjacent regions
(residues 2043–2055 and 2108–2120). In addition, residues
in the HB domain (1857–1915) showed significant chemi-
cal shift changes. This suggested an interaction interface on
the lower flank of Brr2C-Sec63 (Figure 2C). Some residues lo-
cated in other areas of Brr2C-Sec63, such as V2066 andV2067
at the interface of the IG-like and the HB domain, also
showed chemical shift changes, suggesting that direct inter-
actions between Brr2C-Sec63 and FBP21276–376 induce con-
formational rearrangements of the Sec63 unit. Highly sim-
ilar chemical shift changes were observed with the shorter
FBP21326–376 fragment (Supplementary Figure S4), show-
ing that all contacts between FBP21 and Brr2C-Sec63 are
formed by the very C-terminal 50 amino acids.
To gain deeper insights into the nature of the inter-
action, we performed NMR experiments in the pres-
ence of a soluble paramagnetic relaxation enhancer
(PRE), Gadolinium(III)-diethylenetriaminepentacetate
(Gd(DTPA)2−, gadopentetic acid) (50), which can lead to
signal intensity loss for resonances in a theoretical maximal
range of 20–30 A˚. (51–53). Since the PRE effect has a dis-
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Figure 1. The interaction site between FBP21 and Brr2 as derived from cross-linking. (A) Domain organization of FBP21 and Brr2. The domains of the
Brr2NTR are shown in white, the domains of Brr2NC in gray, the domains of Brr2CC in light orange. (B) Cross-links obtained with FBP21200–376 and Brr2
constructs. Numbers in black denote cross-links which were obtained with Brr2CC, numbers in blue denote cross-links with Brr2HR and numbers in light
blue denote cross-links with Brr2FL. (C) Cross-linking sites mapped on the structure of Brr2 (PDB ID 4F91). Brr2NC is shown in gray, Brr2CC in light
orange and Brr2C-Sec63 in beige. Cross-linked residues with more than 10 spectral counts are colored in red, cross-linked residues with fewer spectral counts
in orange.
tance dependency of r−6, strong concentration-dependent
loss of signal intensity upon addition of Gd(DTPA)2−
was only observed for resonances of surface-exposed
residues (Supplementary Figure S5). The experiments
were performed with Brr2C-Sec63 alone and in complex
with FBP21276–376, to qualitatively analyze the interaction
interface. Due to strong spectral overlap, a limited number
of peaks could be analyzed. Some of these corresponded
to residues that were protected by the interaction with
FBP21276–376, indicating that they are directly involved
in binding or that they are changing to a conformation
in which they are less surface-exposed. Other residues
were deprotected, indicating that the interaction with
FBP21276–376 resulted in their increased exposure to the
PRE. The strongly protected residues clustered around the
probable binding site (Figure 2D). Weakly protected and
deprotected residues were found mainly at the interface
of the IG-like and HB domain. Interestingly, strongly
deprotected residues were found at the outward facing end
of the IG-like domain. These residues were not affected by
Gd(DTPA)2− in free Brr2C-Sec63, probably due to shielding
by the negative surface potential of the adjacent HLH
domain (Supplementary Figure S8). Interaction with the
positively charged FBP21276–376 appeared to deprotect this
area, making it accessible for PRE.
By using isothermal titration calorimetry (ITC), we de-
termined the dissociation constants of the interaction be-
tween Brr2C-Sec63 and various fragments of FBP21 (Fig-
ure 3A and Supplementary Figure S6). FBP21200–376 inter-
acted with Brr2C-Sec63 in a one-to-one stoichiometry and a
KD of 125 ± 4 nM. The interaction of FBP21276–376 with
Brr2C-Sec63 displayed a slightly lower affinity with a KD of
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Figure 2. NMR analysis of the interaction between FBP21 and Brr2. (A) Overlay of 1H-15N-TROSY-HSQC spectra of 100 MFBP21276–376 alone (gray)
and in presence of 200 M Brr2 C-Sec63 (blue). (B) Overlay of 1H-15N-TROSY-HSQC spectra of 100 M Brr2C-Sec63 alone (gray) and in presence of 200
M FBP21276–376 (blue). (C) Assignments and chemical shift changes in presence of 400 M FBP21276–376 mapped on the structure of Brr2C-Sec63 (PDB
ID 4F91 (21)) in surface representation. Unassigned residues are shown in beige, assigned residues that have no chemical shift change are shown in dark
gray. Residues exhibiting a chemical shift change upon interaction with FBP21276–376 are shown in two categories. Dark pink denotes a chemical shift
change above the average plus standard deviation of the chemical shift changes of all residues in this experiment ( = 0.157 ppm), light pink denotes a
chemical shift change above the average chemical shift change of all residues in this experiment ( = 0.066 ppm). HB, HLH and IG denote the helical
bundle, helix-loop-helix and immunoglobulin-like domain. (D) Surface representation of the Sec63 unit with mapped differences in peak intensity loss
through Gd(DTPA)2− of free Brr2C-Sec63 and Brr2C-Sec63 in complex with FBP21276–376. Residues in beige could not be analyzed due to spectral crowding
or missing assignments. Residues in shades of pink were protected by the interaction with FBP21276–376, residues in shades of green were more exposed
upon interaction.
298 ± 48 nM in a one-to-one stoichiometry. This was un-
expected, since cross-linking and NMR analysis indicated
that all points of contact are contained in the last 100
residues. The observed difference in binding affinity was
due to a higher gain in enthalpy with the longer fragment.
The last 50 residues of FBP21, FBP21326–376 interacted with
a KD of 110 ± 10 nM. The free enthalpy of the interac-
tion of Brr2C-Sec63 with FBP21276–376 and FBP21326–376, re-
spectively, was very similar. Both interactions were also en-
tropically favored; however, this effect was stronger for the
shorter fragment. These results indicate that an interplay of
various enthalpic and entropic effects governs the affinity of
the FBP21 fragments towards Brr2C-Sec63.
Interaction between Brr2C-Sec63 and FBP21 is partly medi-
ated by a positively charged stretch in FBP21’s C-terminal
region
As FBP21200–376 is intrinsically disordered and appears to
remain disordered upon interaction with Brr2C-Sec63, we
reasoned that it would likely utilize peptidic segments for
the interaction with Brr2. To delineate such putative epi-
topes, we performed peptide SPOT analyses (Figure 3B).
FBP21 was spotted as overlapping 20mer peptides and
binding to various Brr2 constructs was tested (constructs
shown in Figure 1A). The SPOT arrays clearly showed that
a positively charged stretch in FBP21, 357KKRR360, con-
tained in peptides 56–59, interacts with Brr2HR, Brr2CC and
to a lesser extent with Brr2FL. Another positive stretch,
116KKKRK122, contained in peptides 21–24, directly N-
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Figure 3. The interaction between FBP21 and Brr2 is partly mediated by a positively charged peptide contained in FBP21’s C-terminal region. (A) Dis-
sociation constants of FBP21 fragments and Brr2C-Sec63 were determined by ITC. Shown are average KD values and standard deviations derived from
three experiments each. (B) Domain organization of FBP21 as in 1A. Blue bars show the location of the peptides interacting with Brr2 derived from the
peptide SPOT analysis. Brr2CC and Brr2HR interacted with two regions on the SPOT membrane, both of which contained a positively charged stretch. (C)
Excerpt of overlaid 1H-15N-TROSY-HSQC spectra of 100 MBrr2C-Sec63 alone (gray) in presence of sevenfold excess of peptide 57 (beige), in presence of
sevenfold excess of peptide 58 (dark pink) and in presence of a 4-fold excess of FBP21276–376 (blue). Examples of differentially shifting peaks are shown. (D)
The binding sites of peptide 57 and peptide 58 was determined by plotting residues with significant chemical shifts changes on the structure of Brr2C-Sec63
(PDB ID 4F91). Unassigned residues are shown in beige, assigned residues that have no or non-significant chemical shift change are shown in dark gray.
Residues exhibiting a chemical shift change upon interaction with the peptides are shown in pink as two categories. Dark pink denotes a chemical shift
change above the average plus standard deviation of the chemical shift changes of all residues in the experiment (= 0.053 ppm and = 0.109 ppm for
peptide 57 and peptide 58, respectively), light pink denotes a chemical shift change above the average chemical shift change of all residues in the experiment
( = 0.022 ppm and  = 0.040 ppm for peptide 57 and peptide 58, respectively). Circles indicate the negatively charged surface on the HLH domain
that is contacted by all measured FBP21 fragments, arrows indicate residues with chemical shift changes outside of the likely binding site. For comparison
of the binding sites of peptide 57, peptide 58 and FBP21276–376 on Brr2C-Sec63, the residues with chemical shift changes are shown side-by-side using the
same thresholds for all experiments in Supplementary Figure S8.
terminal to theWWdomains, also mediated an interaction.
None of the peptides interacted with Brr2NC.
Peptide 57 (346GVMADGVAPVFKKRRTENGK365,
Figure 3B) was synthesized for further analysis. ITC
measurements confirmed the interaction between peptide
57 and Brr2C-Sec63. With a KD of 27.5 ± 2.2 M, peptide
57 had a substantially lower affinity than the longer
fragments FBP21200–376 and FBP21276–376 (Figure 3A). The
interaction took place in a one-to-one stoichiometry and
seemed to be predominantly driven by entropy. 2D NMR
spectroscopy revealed that the peptide is not sufficient to
induce the extensive changes in the spectrum of Brr2C-Sec63
which were observed with FBP21276–376 (Figure 3C and
Supplementary Figure S7). Fewer resonances showed
chemical shift changes upon interaction of Brr2C-Sec63 with
peptide 57 and the observed chemical shift differences were
substantially smaller. The interaction site was found to be
located to a strongly negatively charged area on the HLH
domain (indicated by a circle in Figure 3D), which is also
part of the binding epitope for FBP21276–376. Accordingly,
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many glutamate residues were affected by the interaction.
M1988, which is flanked by multiple glutamates, showed
the largest chemical shift difference. Slight chemical shift
changes at the interface between IG-like and HB domain
were also observed (indicated by arrows in Figure 3D).
However, the HB domain is only affected by FBP21276–376
binding, indicating an additional contact.
We also analyzed binding of the core binding motif of
peptide 57, 356FKKRR360, to Brr2C-Sec63 by ITC. This pep-
tide showed a similar dissociation constant as peptide 57 (20
± 1.1 M), further consolidating an electrostatic interac-
tion. In ITC experiments with two positively charged con-
trol peptides, GKKRR and KRFKR, KD values of 36.95
± 5.99 M and 27.29 ± 3.01 M, respectively, were mea-
sured, indicating that a positively charged stretch is mainly
responsible for binding to Brr2C-Sec63, while the affinity is
slightly increased by the presence of the aromatic pheny-
lalanine (Supplementary Figure S6).
To further test if and to which extent the positively
charged stretch of FBP21, 356FKKRR360, contributes to
the interaction with Brr2C-Sec63 in context of longer FBP21
fragments, we mutated pairs of positively charged residues
in this region of FBP21200–376 to alanine (K358A/R360A)
or glutamate (K357E/R359E). ITC experiments showed
that both mutants still interacted with Brr2C-Sec63, albeit
with a reduced affinity in comparison to the wild type (KD
of 2.04 ± 0.37 M and 27.8 ± 0.9 M for FBP21200–376
K358A/R360A and FBP21200–376 K357E/R359E, respec-
tively). The 1H–15N-TROSY-HSQC spectrumof Brr2C-Sec63
displayed similar chemical shift changes upon the addition
of the glutamate mutant of FBP21200–376 as upon addition
of the wild-type FBP21276–376 variant (Supplementary Fig-
ure S4). The positively charged stretch thus aids FBP21 to
bindBrr2C-Sec63 but is not responsible for the strong changes
in the NMR spectrum, which seem to additionally require
secondary binding sites.
We wondered whether these binding sites would be
found in proximity to the positively charged sequence
and thus also analyzed the interaction of Brr2C-Sec63 with
peptide 58 (351GVAPVFKKRRTENGKSRNLR370). ITC
measurements revealed a much lower KD value of 1.34 ±
0.19 M and a large enthalpic contribution to the inter-
action. This was surprising, since peptide 57 and peptide
58 overlap to 75%. NMR experiments (Figure 3C and Sup-
plementary Figure S7) revealed that binding of peptide 58
to Brr2C-Sec63 induced chemical shift changes that were in-
termediate between peptide 57 and FBP21276–376 in num-
ber and magnitude. Figure 3C shows the differential ef-
fects of binding by peptide 57, peptide 58 and FBP21276–376
on the chemical shifts of Brr2C-Sec63 in a representative
part of the 1H–15N-TROSY-HSQC spectrum. Some res-
onances are affected by all ligands in a similar fashion
(e.g. 1988M) or show chemical shift changes with increas-
ing magnitudes upon interaction with peptide 57, peptide
58 and FBP21276–376 (e.g. 1983F and 1963L). Still, several
peaks only showed significant chemical shift changes upon
the interaction with FBP21276–376 (e.g. 1905S, 1870Q and
2058Q).Mapping of chemical shift changes on the structure
of Brr2C-Sec63 revealed a larger binding epitope for peptide
58 than for peptide 57 (Figure 3D and Supplementary Fig-
ure S8), encompassing the negatively chargedHLH domain
that was also contacted by peptide 57 (indicated by a circle
in Figure 3D) and the interface of the HLH, HB and IG-
like domains. In addition, strong chemical shift changes of
residues at the interface of HB and IG domains were ob-
served (indicated by arrows in Figure 3D). However, the
lower flank of the HB domain was not contacted by peptide
58, indicating that an additional sequence of FBP21 binds
to this area, also contributing to an additional tenfold affin-
ity increase (KD = 110 ± 10 nM for the interaction between
FBP21326–376 and Brr2C-Sec63).
Binding of FBP21200-376 to Brr2HR leads to reduction of the
Brr2 unwinding activity
To investigate potential functional consequences of the in-
teraction between FBP21200–376 and Brr2, we analyzed the
influence of the interaction on the RNA helicase activity
of Brr2 in vitro. Unwinding of the U4/U6 di-snRNA by
various Brr2 constructs was analyzed in absence and pres-
ence of 600 nMFBP21200–376, which equals a six-fold excess
over Brr2 (Figure 4A). The unwinding activity of Brr2NC
was unchanged upon addition of FBP21200–376 (Figure 4A),
consistent with the FBP21 fragment contacting only the
C-terminal cassette. In contrast, the apparent unwinding
rate of Brr2HR was reduced nearly by half, to a level that
was closer to the unwinding rate of the isolated Brr2NC.
Brr2FL was only slightly inhibited by FBP21200–376. This
observation is in line with the observed lower affinity of
Brr2FL to FBP21200–376 (Supplementary Figure S1). When
using higher concentrations of FBP21200–376 in the unwind-
ing assay with Brr2HR (1–10 M), the unwinding rate was
further reduced, but more noticeably, the unwound frac-
tion was strongly decreased (Figure 4D and Supplemen-
tary Figure S10), indicating a pool of U4/U6 di-snRNA
which cannot be unwound by Brr2. These results suggest
that FBP21200–376 can inhibit Brr2 helicase activity by two
distinct mechanisms. At low concentrations, the fragment
may predominantly bind the Brr2 C-terminal cassette and
functionally uncouple the two cassettes of Brr2, leading to
reduction of the unwinding rate. At high concentrations,
FBP21200–376 may additionally bind the U4/U6 di-snRNA
and make it unavailable for unwinding by Brr2, leading to
the observed lower amplitude of unwinding.
To test the above hypotheses, we conducted RNA bind-
ing studies with FBP21200–376. At concentrations above 400
nM, FBP21200–376 induced electrophoretic mobility shifts of
U4/U6 di-snRNA (Supplementary Figure S9). Quantifica-
tion of the data revealed an apparent KD of 0.78 M for
the interaction. The affinity forU4 snRNAwas significantly
lower (apparent KD = 3.5 M, Figure 4B), and no interac-
tion could be detected with U6 snRNA (data not shown).
FBP21200–376 at a concentration of 5M,which equals a 60-
fold excess at the final point of the titration, competed with
Brr2 for RNA binding and reduced the affinity between
U4/U6 duplex and Brr2HR by a factor of five (Figure 4C).
In contrast, at low concentrations (600 nM), FBP21200–376
had little effect on RNA binding by Brr2HR (Figure 4C),
indicating that the observed lower unwinding amplitude is
not caused by direct substrate competition.
To further test the influence of RNA binding by FBP21
on U4/U6 di-snRNA unwinding by Brr2, we performed
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Figure 4. FBP21 regulates the helicase activity of Brr2 by two distinct mechanisms. (A) U4/U6 di-snRNA unwinding assays with 100 nM Brr2NC, Brr2HR
and Brr2FL and absence and presence of 600 nM FBP21200–376. Unwinding rate (kunwinding) and amplitudes are given in the table. FBP21200–376 strongly
inhibits Brr2HR and slightly inhibits Brr2FL. (B) U4/U6 di-snRNA and U4 snRNA binding of FBP21 fragments derived from EMSA experiments and
affinites derived from fitting. (C) U4/U6 snRNA binding of Brr2HR derived from EMSA experiments in presence of FBP21200–376 or FBP21276–376.
FBP21200–376 inhibits RNA binding of Brr2HR when present in high concentrations. The inhibition is reduced when the shorter FBP21276–376 is used in the
assay. (D) Concentration dependence of the inhibition of Brr2HR by FBP21200–376. The relative unwinding rate and relative reaction amplitude decrease
with increasing concentrations of FBP21. (E) Concentration dependence of the inhibition of Brr2HR by FBP21276–376. The unwinding rate is reduced in a
concentration-independent manner when a stoichiometric complex is formed. The relative amplitude stays constant at all concentrations. (F) U4/U6 di-
snRNA unwinding assays with 1 MFBP21326–376 show that FBP21326–376 has no inhibitory effect on BrrHR. (G) U4/U6 di-snRNA unwinding assays of
100 MBrr2HR in presence of equimolar amounts of Prp8Jab1C with or without 600 nM FBP21200–376. The activatory effect of Prp8Jab1C is completely
abolished in presence of FBP21200–376. All datapoints were taken in at least three independent replicates. The plots show the average and standard deviation
of the collected datapoints. Unwinding rates and amplitudes are given as best-fit values ± standard error.
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unwinding assays with FBP21276–376 (Figure 4E and Sup-
plementary Figure S10) which did not interact with U4/U6
di-snRNA in electrophoretic mobility shift assay (EMSAs)
(Figure 4B and Supplementary Figure S9). As expected,
FBP21276–376 reduced the unwinding rate of Brr2HR approx-
imately two-fold, similar to FBP21200–376. However, exper-
iments employing high concentrations of FBP21276–376 re-
vealed the same reduction in unwinding rate, but no de-
crease in the unwound fraction (Figure 4E and Supplemen-
tary Figure S9). We thus conclude that the interaction of
FBP21 with Brr2HR directly modulates helicase activity by
functionally uncoupling N- and C-terminal cassettes, and
that FBP21 at higher concentrations additionally inhibits
the unwinding of a pool of U4/U6 di-snRNA by a yet un-
knownmechanism that depends on the direct interaction of
FBP21 with the U4/U6 di-snRNA.
Interestingly, the shorter FBP21326–376 did not af-
fect Brr2HR helicase activity. This indicates that al-
though FBP21326–376 covers the complete binding site on
Brr2C-Sec63, it lacks additional contacts that appear to be
responsible for helicase inhibition and may also increase
the interaction affinity (Figure 4F). Cross-links at the in-
terface of Brr2C-Sec63 and the C-terminal RecA-2 domain to
FBP21200–376 suggest that the contacts aremade in this area.
Interplay with other spliceosomal components
Brr2 is known to be regulated by the C-terminal Jab1 do-
main of Prp8. The intrinsically disordered tail can inter-
mittently inhibit Brr2, while a C-terminally truncated ver-
sion of the Jab1 domain (Prp8Jab1C) acts as a strong ac-
tivator of the Brr2 helicase. We thus asked whether the in-
hibitory effect of FBP21 is still observedwhenBrr2 is bound
to Prp8Jab1C. Size exclusion chromatography revealed that
FBP21276–376 can bind simultaneously with Prp8Jab1C to
Brr2HR (Supplementary Figure S1). Interestingly, this was
not the case for FBP21326–376. Unwinding assays showed
that the Prp8Jab1C activation of Brr2HR helicase activity is
strongly reduced in the presence of FBP21200–376 (from 0.57
min−1 to 0.21 min−1; Figure 4G). In summary, it appears
that Prp8Jab1C and FBP21 compete for Brr2HR regulation,
which may be important for timing of FBP21-mediated in-
hibition and Prp8Jab1C-mediated activation.
FBP21 is known to interact with PRS via its WW do-
mains. As the PRS in the C-terminal tail of SmB/B’ is
a well-described interaction partner of FBP21 (37,54), we
wondered whether the interactions between FBP21 and
Brr2 and FBP21 and the SmB-derived peptide (GTPMGM
PPPGMRPPPPGMRGLL) are independent of each other.
ITC experiments were performed with a fragment of FBP21
that encompasses the WW domains and the Brr2-binding
C-terminal domain (FBP21116–376) (Supplementary Figure
S11). The direct interaction between each set of interaction
partners was analyzed. The dissociation constant between
FBP21116–376 and SmB-peptide was found to be 16.8 ± 3.0
M,which is in agreement with previously reportedKD val-
ues (37). The dissociation constant between FBP21116–376
andBrr2C-Sec63 was 275± 106 nM,which agrees with theKD
values that were measured for the other fragments (Supple-
mentary Figure S6). Brr2C-Sec63 itself did not interact with
the SmB-peptide (Supplementary Figure S11). The interac-
tions of FBP21116–376 with SmB-peptide and FBP21116–376
with Brr2C-Sec63 after pre-incubation of FBP21116–376 with
the respective other binding partner showed KD values of
14.0 ± 0.8 M and 194 ± 14 nM, respectively. This is
in good agreement with the dissociation constants of the
binary interactions and shows that they occur indepen-
dently (Supplementary Figure S11). In vitro unwinding as-
says showed that FBP21116–376 inhibited the Brr2HR helicase
activity to a similar extent as FBP21200–376 (Supplementary
Figure S11H). Together, these results suggest that the in-
hibitory effect of FBP21 on Brr2 and the interactions of
FBP21with SmBare orthogonal and allow the construction
of a model, in which FBP21 interacts with both proteins in
the context of the B complex (Figure 5).
DISCUSSION
Here, we have used a yeast-two-hybrid screen in combi-
nation with biochemical and biophysical analyses to un-
cover a molecular function of the B complex-specific pro-
tein FBP21. We identified 15 putative spliceosomal FBP21
interaction partners. Many of them are consistent with a
role in the B complex; among them are core spliceosomal
proteins (Brr2, SF3B2, SF3A1) (31), the U4/U6-related
protein PPIH (31,55) and some putative interaction part-
ners that are implicated mainly in splice site definition (AR-
GLU1, TIA-1, hnRNPK) and may also be present in later
stages (56). A couple of the identified interaction partners
are predominantly found in later stages, such as the Prp19-
associated ISY1 (57) and WBP11 (31,58), the Bact complex
associated SKIP (59), the C complex-associated MORG1
(31) and the helicases Prp16 and Prp43. ISY1, WBP11 and
SKIP are also found to aminor extent in the B complex (31),
allowing for an interaction at this stage. Many of the inter-
actions with later stage proteins (WBP11, ISY1, Prp16 and
Prp43) are PRS-mediated and may therefore be detected in-
dependent of the spliceosomal complex they are associated
with.
The interaction with the spliceosomal RNAhelicase Brr2
was analyzed in further detail. We found that FBP21 inter-
acts via its C-terminal region (residues 200–376) with the
C-terminal cassette of Brr2. The interaction is mediated to
a large extend by the C-terminal Sec63 unit of Brr2 and de-
pends on a network of multiple contacts.
A positively charged stretch in FBP21 (residues 356–360)
confers interaction affinity andmay play a role for establish-
ing a primary contact between the proteins. The interaction
takes place at theHLHdomain of theC-terminal Sec63 unit
in Brr2 (residues 1960–2020), and its interface to the HB
and IG domains (binding site A in Figure 5) as revealed by
NMRmeasurements. The cross-linking data confirmed that
the very C-terminal region of FBP21 containing the posi-
tively charged stretch is oriented towards the IG and HLH
domains of the Brr2 C-terminal cassette. This area presents
a strongly negatively charged surface due to an accumula-
tion of glutamate residues. This feature is not seen in the N-
terminal Sec63 unit, explaining why despite its highly sim-
ilar structure, the N-terminal Sec63 unit does not interact
with FBP21. The interaction is strongly favored by an en-
tropy gain, which is common for electrostatic interactions.
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Figure 5. A model of FBP21 in the spliceosome. (A) Binding site of FBP21 on Brr2. The N-terminal helicase cassette is shown in gray, the C-terminal
helicase cassette in light orange and the C-terminal Sec63 domain in beige. Pink and light pink residues showed chemical shift changes inNMR experiments
with FBP21276–376. Residues that cross-linked to FBP21200–376 are shown in red (>10 spectral counts) and orange (<10 spectral counts). From these
experiments, three contact sites were derived. (B) FBP21 interacts with Brr2 via the binding sites described in A. FBP21 is drawn in blue. Areas in which the
interaction site is well established are drawn with a solid line, areas about which less information is available are drawn in dashed lines. FBP21 additionally
interacts with SmB/B’ (Sm ring in green, C-terminal tail of SmB/B’ shown as a green dashed line) via its WW domains (PDB ID 2JXW). The orientation
of Brr2, and the structure of the Sm ring and the U4 RNA are derived from an ‘activated’ yeast U4/U6•U5 tri-snRNP (PDB ID 5GAN).
The region directly C-terminal to the positively charged
stretch in FBP21 also contacts the Sec63 unit, leading to
more pronounced chemical shift changes and an increased
binding affinity for a peptide comprising both elements.
Interestingly, this contact induced stronger chemical shift
changes between the HB and IG domains, distant from the
probable binding site (Figure 3D and Supplementary Fig-
ure S8). These chemical shift changes likely arise from a mi-
nor conformational rearrangement rather than from a di-
rect interaction. This is supported by the finding that bind-
ing of FBP21276–376 to the Sec63 unit leads to a change in
surface exposure of residues in that area (Figure 2D).
An additional contact is established between the C-
terminal region of FBP21 and the C-terminal Sec63 unit
of Brr2, which leads to higher affinity through a strong en-
thalpy gain upon complex formation. We observed strong
chemical shift changes in the NMR spectrum of Brr2C-Sec63
upon addition of FBP21276–376, which affects residues that
are localized mainly on an extended surface epitope, which
stretches across the Sec63 unit towards the RecA-2 domain
of Brr2CC (binding site B in Figure 5). This binding inter-
face agrees both with strongly protected areas in the PRE
experiments and with the observed cross-links.
The region of FBP21 (within residues 326–356), which
occupies binding site B on Brr2C-Sec63, was not identified
in the peptide SPOT array. One explanation for this ob-
servation could be that the additional contact site requires
the formation of a secondary structure in FBP21, which
is not adopted by the isolated peptide. While we cannot
exclude more transiently formed secondary structures to
be populated in the bound state, the HSQC spectrum of
FBP21276–376 appeared to remain consistent with an IDPR
upon binding. Another possible explanation is that FBP21
remains largely unstructured upon binding to Brr2 and
forms a so-called fuzzy complex, i.e. a complex which sam-
ples various bound conformations (60). This type of inter-
action would be difficult to replicate with a short peptide
and would thus not show up in a SPOT array. A fuzzy
FBP21–Brr2 interaction would also explain our difficulties
to crystallize the complex and may rationalize the different
enthalpic and entropic properties of the interaction made
by different FBP21 fragments.
Using its C-terminal 100 residues, FBP21 also contacts
regions of Brr2CC outside of the Sec63 unit (binding site C
in Figure 5), as indicated by the differential effects of FBP21
fragments with different lengths on the Brr2 helicase ac-
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tivity. These extended interactions are important for direct
FBP21-dependent Brr2 modulation.
The interaction of FBP21 with Brr2 influences Brr2 heli-
case activity in vitro by two distinct mechanisms. FBP21 re-
duces the pool of U4/U6 di-snRNA that can be unwound
by Brr2 by interacting itself with the U4/U6 di-snRNA.
Since only a large excess of FBP21 reduces the apparent
affinity of Brr2 for its substrate, this is likely not a conse-
quence of direct competition.However, blocking of the Brr2
binding site may be possible at particular stages of splicing,
e.g. during pre-B to B complex transition when all factors
are present at high effective concentrations in the spliceo-
some, but Brr2 is not yet bound to its substrate. Possibly,
FBP21 could also interact with Brr2 and the U4/U6 di-
snRNA simultaneously, which may lead to stalling of the
helicase and thereby to the observed lower unwinding am-
plitude. Future investigations will hopefully further eluci-
date the mechanism by which RNA-binding of FBP21 in-
fluences the unwinding reaction.
Moreover, our observation that the interaction of
FBP21276–376 with Brr2CC leads to a decrease of the appar-
ent unwinding rate of Brr2HR indicates that FBP21 addi-
tionally influences one or several steps of Brr2-mediated
U4/U6 unwinding directly. In isolated Brr2, the inactive
C-terminal cassette acts as an intramolecular cofactor that
stimulates the helicase activity of the N-terminal cassette
by direct or indirect (e.g. via the substrate) interactions be-
tween the cassettes. Based on our observations, we suggest
that FBP21 binding to the C-terminal cassette allosterically
modulates the intramolecular contacts and thus the func-
tional communication between the Brr2 helicase cassettes.
Consistent with this interpretation, addition of FBP21 to
Brr2HR reduces the unwinding activity to the level of the
isolated N-terminal cassette.
The functional interplay between FBP21, Brr2HR and
Prp8Jab1C may also be governed by allostery. FBP21 and
Prp8Jab1C do not compete for an interaction site on
Brr2HR, however, while FBP21276–376 forms a stable com-
plex with Brr2HR-Prp8Jab1C, FBP21326–376 is not able to
stably associate with a pre-formed Brr2HR–Prp8Jab1C com-
plex. Thus, the additional contact of the longer FBP21
fragment, which also influences helicase activity, is neces-
sary for the protein to bind Brr2 in presence of Prp8Jab1C.
Meanwhile, FBP21 binding overrides the helicase acti-
vating effect of Prp8Jab1C in unwinding assays. There-
fore, FBP21 and Prp8Jab1C seem to compete for Brr2
regulation––Prp8Jab1C may induce an ‘activated’ confor-
mation, which is incompatible with binding of the truncated
FBP21 fragment. In contrast, FBP21 bindingmay induces a
‘muted’ conformation, which allows for Prp8Jab1C binding
but inhibits the activation by Prp8Jab1C.
Other splicing factors have been shown to interact with
the C-terminal cassette of Brr2 (27,28,30,61) although the
exact binding sites are unknown for most of them. It will be
highly interesting to see whether these proteins also exert an
effect on Brr2 helicase activity and regulate the helicase in
the different spliceosomal complexes.
The interaction between FBP21 and Brr2 we described
in this study is very likely to have important effects dur-
ing splicing. FBP21 is thought to be stably integrated
into the spliceosome exclusively at the B complex stage
(31). Although no structure of a human spliceosomal
B complex is yet available, recent structural studies of
U4/U6•U5 tri-snRNPs provide some insight into how
FBP21-dependent Brr2 regulation could take place. The po-
sition of Brr2 is drastically different in structures of human
and yeast U4/U6•U5 tri-snRNPs (30,62,63). In the human
tri-snRNP structure, Brr2 is located remote from its U4/U6
substrate and its N-terminal region is wrapped around the
helicase core. In this ‘resting’ conformation, the tri-snRNP
is stable in the presence of ATP. Since the interaction of
FBP21 with Brr2 in the locked conformation is consider-
ably weakened, this situation can explain why FBP21 does
not stably associate with the tri-snRNP via Brr2 outside of
the spliceosome. In stark contrast, in the yeast tri-snRNP
structure, Brr2 is bound to its U4/U6 substrate and seems
poised for unwinding, consistent with the observed lability
of this particle in the presence of ATP (30). The Brr2NTR
is peeled off the helicase region and is engaged in protein-
protein interactions with other subunits of the tri-snRNP.
The yeast tri-snRNP structure could thus resemble the state
of the tri-snRNP within the B complex immediately before
Brr2-mediated U4/U6 unwinding is initiated. Within this
structure, Brr2CC and in particular Brr2C-Sec63 are exposed
and could easily engage in an interaction with FBP21. The
Sm ring of U4 is located in close proximity. FBP21 might
thus employ its WW domains to additionally interact with
the PRS-tail of SmB. This would likely reinforce the direct
effect FBP21 can exert on Brr2, thus delaying U4/U6 un-
winding and thereby spliceosome activation.
In conclusion, we have identified a novel role for FBP21
as a key player in Brr2 regulation. FBP21modulates the two
helicase cassettes of Brr2 and affects snRNA binding and
unwinding at a checkpoint of splicing regulation. As FBP21
was suggested previously tomodulate alternative splicing, it
will be interesting to see how FBP21-mediated Brr2 inhibi-
tion translates into distinct splice site decision in the cell.
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